FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34692311000001100: Maviret 100mg/40mg tablets (AbbVie Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104987001000001111 Maviret 100mg/40mg tablets (AbbVie Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104987101000001112 Maviret 100mg/40mg tablets (AbbVie Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Maviret 100mg/40mg tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Is a Glecaprevir 100mg / Pibrentasvir 40mg tablets true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has specific active ingredient Glecaprevir false Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has specific active ingredient Pibrentasvir false Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Is a Maviret true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has active ingredient Substance with antiviral mechanism of action true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has specific active ingredient Pibrentasvir true Inferred relationship Existential restriction modifier
Maviret 100mg/40mg tablets (AbbVie Ltd) Has specific active ingredient Glecaprevir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Maviret 100mg/40mg tablets (AbbVie Ltd) 84 tablet 4 x 21 tablets Has AMP True Maviret 100mg/40mg tablets (AbbVie Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start